Tag Archives: Alzheimer’s Association

8 Reasons New Medicines are Needed for Alzheimer’s

synthetic biology

Last week, the Alzheimer’s Association released an infographic with eight mythbusting facts to help dispel common misconceptions about the disease when it comes to prevention, financial impact, symptoms, and other areas. As the infographic confirms, there is no cure for this irreversible neurological disease, and only half of people living with Alzheimer’s (the 6th leading cause of death in the US) have actually been diagnosed. PhRMA’s report on Medicines in Development for Alzheimer’s Disease notes Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Coalition Offers a Remedy for Stagnated Clinical Trials


Promising new clinical trial data offers fresh hope for the families of Alzheimer’s patients.  A new medication seems to be slowing the disease’s progress, limiting the cognitive decline that characterizes this “long goodbye.” Wouldn’t it be wonderful for patients suffering other diseases to have equally encouraging prospects? But many do not. Part of the problem lies with clinical trials.  For a new medication to receive FDA approval, it must undergo comprehensive testing on actual patients.  Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Alzheimer’s Association offers Research Grant Program

Heather Snyder picture copy

The Alzheimer’s Association offers the Part the Cloud Translational Research Grant Program, which aims to fill the gap in Alzheimer’s disease drug development. The program supports early phase studies of potential Alzheimer’s therapeutics or validation of biological markers of disease progression and moves us closer to potential therapies to stop or slow the progression of Alzheimer’s. More information is available at alz.org/grants. There is no greater health care need than slowing or preventing Alzheimer’s disease. Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,